Related references
Note: Only part of the references are listed.The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Nathan Reynders et al.
CELLS (2019)
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
Vitalijs Ovcinnikovs et al.
SCIENCE IMMUNOLOGY (2019)
Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis
Yi-hui Wen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy
Lixia Zhang et al.
ONCOLOGY LETTERS (2019)
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
Anu Sharma et al.
CLINICAL CANCER RESEARCH (2019)
Regulatory T cells: a potential target in cancer immunotherapy
Kohei Shitara et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas et al.
CANCER CELL (2018)
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Xuexiang Du et al.
CELL RESEARCH (2018)
Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients
Qiang Ma et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Anti-CTLA-4 therapy requires an Fc domain for efficacy
Jessica R. Ingram et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities
Jae Eun Cheong et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Santosh Kumar Singh et al.
SCIENTIFIC REPORTS (2018)
Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
Fei Tang et al.
CELL AND BIOSCIENCE (2018)
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Human Regulatory T Cell Potential for Tissue Repair Via IL-33/ST2 and Amphiregulin
Avery J. Lam et al.
TRANSPLANTATION (2018)
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
Katharina Helene Susek et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
Jean-Jacques Fournie et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular diversification of regulatory T cells in nonlymphoid tissues
Joanna R. DiSpirito et al.
SCIENCE IMMUNOLOGY (2018)
IDO1: An important immunotherapy target in cancer treatment
Fangxuan Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis
Michael P. Holt et al.
JOURNAL OF IMMUNOLOGY (2017)
Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas
Maren Wallesch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells
Stephanie Downs-Canner et al.
NATURE COMMUNICATIONS (2017)
Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer
Fangxuan Li et al.
ONCOTARGET (2017)
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Marie-Helene Wasmer et al.
FRONTIERS IN IMMUNOLOGY (2017)
'Repair' Treg Cells in Tissue Injury
Chaoqi Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Interleukin-10-regulated tumour tolerance in non-small cell lung cancer
Julius Malte Vahl et al.
BRITISH JOURNAL OF CANCER (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model
De-Kuan Chang et al.
ONCOIMMUNOLOGY (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Molecular Pathways: Interleukin-35 in Autoimmunity and Cancer
Yuliya Pylayeva-Gupta
CLINICAL CANCER RESEARCH (2016)
Immunosuppressive activities of adenosine in cancer
Bertrand Allard et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells
Wilson Kuswanto et al.
IMMUNITY (2016)
CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
Chang Xian Li et al.
JOURNAL OF HEPATOLOGY (2016)
The IL-33/ST2 axis: Role in health and disease
Marjorie De la Fuente et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Regulatory T Cells Promote β-Catenin-Mediated Epithelium-to-Mesenchyme Transition During Radiation-Induced Pulmonary Fibrosis
Shanshan Xiong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS
Sharad K. Mittal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
Peter Hsu et al.
JOURNAL OF IMMUNOLOGY (2015)
Confocal Imaging-Guided Laser Ablation of Basal Cell Carcinomas: An Ex Vivo Study
Heidy Sierra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice
Kailash Singh et al.
SCIENTIFIC REPORTS (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome
Sara Omenetti et al.
FRONTIERS IN IMMUNOLOGY (2015)
Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV
Theresa L. Whiteside
CANCER MICROENVIRONMENT (2015)
Neuropilin 1: function and therapeutic potential in cancer
Belal Chaudhary et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
Theresa L. Whiteside
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis
Rui-Cheng Ji
CANCER LETTERS (2014)
Perforin: an important player in immune response
Iwona Osinska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2014)
The potential to target CCL5/CCR5 in breast cancer
Marco Velasco-Velazquez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Circulating IL-35 in pancreatic ductal adenocarcinoma patients
Peng Jin et al.
HUMAN IMMUNOLOGY (2014)
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
Ahmad A. Tarhini et al.
PLOS ONE (2014)
Effective Chemoimmunotherapy with Anti-TGFβ Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer
Xin Chen et al.
PLOS ONE (2014)
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors
Hatem H. Soliman et al.
ONCOTARGET (2014)
S1PR1 Is Crucial for Accumulation of Regulatory T Cells in Tumors via STAT3
Saul J. Priceman et al.
CELL REPORTS (2014)
Role of aryl hydrocarbon receptor in cancer
Shaolong Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
Epidermal Growth Factor Receptor-Containing Exosomes Induce Tumor-Specific Regulatory T Cells
Shao-hong Huang et al.
CANCER INVESTIGATION (2013)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Dalia Burzyn et al.
CELL (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
TGF-beta signaling and epithelial-mesenchymal transition in cancer progression
Yoko Katsuno et al.
CURRENT OPINION IN ONCOLOGY (2013)
Current status of interleukin-10 and regulatory T-cells in cancer
Kristen L. Dennis et al.
CURRENT OPINION IN ONCOLOGY (2013)
Modulation of Treg cells/T effector function by GITR signaling is context-dependent
Amal Ephrem et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients
Agnieszka Piechnik et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
Antoni Ribas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
Yannick Bulliard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Comparison of Induced versus Natural Regulatory T Cells of the Same TCR Specificity for Induction of Tolerance to an Environmental Antigen
Hui Huang et al.
JOURNAL OF IMMUNOLOGY (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer
Ya-Qing Li et al.
PLOS ONE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Neuropilin-1 in transplantation tolerance
Mauricio Campos-Mora et al.
FRONTIERS IN IMMUNOLOGY (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Tumor-Derived Chemokine CCL5 Enhances TGF-β-Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang et al.
CANCER RESEARCH (2012)
CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Nassima Redjimi et al.
CANCER RESEARCH (2012)
Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35
Maria Bettini et al.
DIABETES (2012)
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
Wiebke Hansen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo
Mahesh Yadav et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Human Prostate Tumor Antigen-Specific CD8+ Regulatory T Cells Are Inhibited by CTLA-4 or IL-35 Blockade
Brian M. Olson et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Autocrine-Derived Epidermal Growth Factor Receptor Ligands Contribute to Recruitment of Tumor-Associated Macrophage and Growth of Basal Breast Cancer Cells In Vivo
Nicole K. Nickerson et al.
ONCOLOGY RESEARCH (2012)
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Jonas Fuxe et al.
SEMINARS IN CANCER BIOLOGY (2012)
What are regulatory T cells (Treg) regulating in cancer and why?
Theresa L. Whiteside
SEMINARS IN CANCER BIOLOGY (2012)
Sphingosine-1-phosphate signaling and its role in disease
Michael Maceyka et al.
TRENDS IN CELL BIOLOGY (2012)
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells
Michael Romio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
High FOXP3+regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer
Chao-Hsu Li et al.
IMMUNOLOGIC RESEARCH (2011)
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato et al.
IMMUNOLOGIC RESEARCH (2011)
Knock-Down of Amphiregulin Inhibits Cellular Invasion in Inflammatory Breast Cancer
Andrea Baillo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2011)
Foxp3(+)IL-17(+) T cells promote development of cancer-initiating cells in colorectal cancer
Shaobo Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis
Narendra P. Singh et al.
PLOS ONE (2011)
Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis
Kang-Jie Chen et al.
PLOS ONE (2011)
Indoleamine 2,3-Dioxygenase Is It an Immune Suppressor?
Hatem Soliman et al.
CANCER JOURNAL (2010)
Granzymes in cancer and immunity
S. P. Cullen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients
Liufu Deng et al.
CLINICAL CANCER RESEARCH (2010)
Enrichment of CCR6(+)Foxp3(+) regulatory T cells in the tumor mass correlates with impaired CD8(+) T cell function and poor prognosis of breast cancer
Lin Xu et al.
CLINICAL IMMUNOLOGY (2010)
CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma
T. Maruyama et al.
DISEASES OF THE ESOPHAGUS (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3(+) T Regulatory Cells
Angela M. Thornton et al.
JOURNAL OF IMMUNOLOGY (2010)
Advanced Colorectal Cancer Is Associated With Enhanced IL-23 and IL-10 Serum Levels
Noyko Stanilov et al.
LABMEDICINE (2010)
Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
Yuzo Suzuki et al.
LUNG CANCER (2010)
IL-35-mediated induction of a potent regulatory T cell population
Lauren W. Collison et al.
NATURE IMMUNOLOGY (2010)
Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)
Marta Szajnik et al.
PLOS ONE (2010)
Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
Dorothea Busse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Jacqueline D. Shields et al.
SCIENCE (2010)
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
Alessandra Battaglia et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Magis Mandapathil et al.
CLINICAL CANCER RESEARCH (2009)
CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion
Xue-Jun Qin et al.
CLINICAL CANCER RESEARCH (2009)
Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer
Rikiya Nakamura et al.
EUROPEAN JOURNAL OF CANCER (2009)
Dynamics of peripheral tolerance and immune regulation mediated by Treg
Shimon Sakaguchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1
Wendy W. J. Unger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Maria A. Curotto de Lafaille et al.
IMMUNITY (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
Eva U. Wieckowski et al.
JOURNAL OF IMMUNOLOGY (2009)
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
Markus Feuerer et al.
NATURE MEDICINE (2009)
Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition
Milka Sarris et al.
IMMUNITY (2008)
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer
Alessandra Battaglia et al.
IMMUNOLOGY (2008)
The T-cell receptor repertoire of regulatory T cells
Rafal Pacholczyk et al.
IMMUNOLOGY (2008)
Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target
Dorothy K. Sojka et al.
IMMUNOLOGY (2008)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II
Bitao Liang et al.
JOURNAL OF IMMUNOLOGY (2008)
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
Yasushi Onishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells
Akihiro Kimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Justin T. Jordan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Lauren W. Collison et al.
NATURE (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Transforming growth factor-β and the immune response:: Implications for anticancer therapy
Stephen H. Wrzesinski et al.
CLINICAL CANCER RESEARCH (2007)
A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Activated CD4+CD25+ T cells selectively kill B lymphocytes
Dong-Mei Zhao et al.
BLOOD (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies
KD Lute et al.
BLOOD (2005)
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
DD Taylor et al.
BRITISH JOURNAL OF CANCER (2005)
Neuropilin-1: a surface marker of regulatory T cells
D Bruder et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
TGF-β induces Foxp3+T-regulatory cells from CD4+CD25-precursors
S Fu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro
X Lu et al.
NEOPLASIA (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Overview of interleukin-2 function, production and clinical applications
SL Gaffen et al.
CYTOKINE (2004)
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
BW Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
An essential role for Scurfin in CD4+CD25+ T regulatory cells
R Khattri et al.
NATURE IMMUNOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cytokines and immune response in the tumor microenvironment
S Mocellin et al.
JOURNAL OF IMMUNOTHERAPY (2001)
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
B Salomon et al.
IMMUNITY (2000)
Share Paper
